GW Pharmaceuticals PLC- Company Profile (NASDAQ:GWPH)

Analyst Ratings

Consensus Ratings for GW Pharmaceuticals PLC- (NASDAQ:GWPH) (?)
Ratings Breakdown: 2 Sell Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $133.67 (41.18% upside)

Analysts' Ratings History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
Show:
DateFirmActionRatingPrice TargetActions
7/18/2016Bank of America Corp.Reiterated RatingBuy$153.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Leerink SwannReiterated RatingOutperform$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Goldman Sachs Group Inc.Lower Price Target$135.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Morgan StanleyBoost Price TargetOverweight$149.00 -> $152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2016Piper Jaffray Cos.Reiterated RatingBuy$147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Cowen and CompanyReiterated RatingBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Janney Montgomery ScottInitiated CoverageSell$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Roth CapitalBoost Price TargetBuy$130.00 -> $160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Numis Securities LtdInitiated CoverageSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014Peel HuntDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/5/2016Q216($1.57)($0.09)$5.99 million$3.81 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q116($1.53)($0.10)$4.61 million$5.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/7/2015Q415($1.37)($0.85)$15.00 million$5.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q315($1.30)($1.60)$12.82 million$13.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q215($1.23)($0.58)$11.38 million$9.43 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q115($1.25)($0.02)$12.12 million$12.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/2/2014Q414($0.69)$0.02$9.15 million$12.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q314($1.08)$0.06$12.88 million$13.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.48)($0.04)$12.48 million$12.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413($0.34)($0.02)$11.54 million$7.49 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2013Q4($0.19)($0.29)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2013Q313($0.11)$0.02$10.71 million$11.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($2.35)($1.98)($2.13)
Q2 20163($2.40)($1.44)($2.00)
Q3 20163($2.23)($1.44)($1.89)
Q4 20161($1.62)($1.62)($1.62)
Q1 20171($1.80)($1.80)($1.80)
Q2 20171($1.98)($1.98)($1.98)
Q3 20171($2.34)($2.34)($2.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
DateHeadline
07/23/16 04:08 PM3 Reasons Momentum Stock Investors Will Love GW Pharmaceuticals (GWPH) - Nasdaq
07/22/16 07:46 AM3 Reasons Momentum Stock Investors Will Love GW Pharmaceuticals (GWPH) -
07/22/16 07:16 AMEarnings Focus and Crowd Sourced Sentiment Review for GW Pharmaceuticals Plc (NASDAQ:GWPH) - TGP
07/22/16 07:16 AMGW Pharmaceuticals Plc Ads (NASDAQ:GWPH) Shorted Shares Increased By 1.58% - Consumer Eagle
07/20/16 02:16 PMEquity Update - Focusing on Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) - Engelwood Daily
07/20/16 02:16 PMGW Pharmaceuticals Plc (GWPH) Current Analyst Ratings - Fiscal Standard
07/20/16 07:12 AMGW Pharmaceuticals Plc (NASDAQ:GWPH) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/19/16 10:28 AMGW Pharmaceuticals : Closes US Public Offering, Raising USD289.8 Million (ALLISS)
07/18/16 04:32 PMTracking Trading Performance for: GW Pharmaceuticals Plc (NASDAQ:GWPH) - TGP
07/18/16 04:32 PMMarket Motion Watch - Focus on Shares of: GW Pharmaceuticals Plc (NASDAQ:GWPH) - TGP
07/18/16 10:15 AMGW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising $289.8 Million on the NASDAQ Global Market and Full Exercise of Underwriter’s Option to Purchase Additional ADSs - [GlobeNewswire] - LONDON, July 18, 2016-- GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, ...
07/18/16 09:32 AMGW Pharmaceuticals Plc (NASDAQ:GWPH) Taking a Look at the Current Company Impact Score - Press Telegraph
07/15/16 03:24 PMCurrent Sentiment and Impact Score Watch:GW Pharmaceuticals Plc (NASDAQ:GWPH):GW Pharmaceuticals Plc ... - Press Telegraph
07/15/16 07:27 AMActive Eye Catching Stocks- United Technologies (NYSE:UTX), GW Pharmaceuticals (NASDAQ:GWPH), ADTRAN ... - Seneca Globe
07/15/16 07:27 AMPerformance Overview of the company: GW Pharmaceuticals plc (NASDAQ:GWPH) - News Oracle
07/15/16 07:27 AMMerrill Lynch Remains Bullish on GW Pharmaceuticals PLC- ADR (GWPH) Following Equity Offering - Smarter Analyst
07/15/16 06:22 AMMedtronic's IN.PACT Admiral DCB Wins FDA Nod for 150 mm -
07/14/16 07:49 AMNew Broker Ratings For GW Pharmaceuticals Plc (GWPH) - FTSE News
07/13/16 04:44 PMGW Pharma says to raise $252 million via public offering
07/13/16 04:44 PMGW Pharma to raise quarter of a billion dollars from US investors
07/13/16 04:44 PMGW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Raising $252.0 Million on NASDAQ Global Market
07/13/16 08:27 AMGW Pharmaceuticals To Raise Money For Epidiolex -
07/13/16 07:12 AMGW Pharma (GWPH) Prices 2.8M Share Offering at $90/ADS - StreetInsider.com
07/13/16 06:07 AMCytRx (CYTR) Stock Falls on Unfavorable Aldoxorubicin Data -
07/13/16 03:22 AMGW Pharma to raise $252 million after cannabis drug success -
07/13/16 03:21 AMGW Pharma to raise $252 mln after cannabis drug success - [Reuters] - British drug developer GW Pharmaceuticals Plc said it would raise $252 million through the issue of 2.8 million shares on the Nasdaq. Shares in the company have been gaining after positive trial results of its experimental drug Epidiolex, and have notched up gains of more than 50 percent this year, shrugging off early declines. GW Pharma's drug reduced the incidence of seizures in people suffering from rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.
07/12/16 04:36 PMBRIEF-GW Pharmaceuticals announces proposed public offering of ADSs
07/12/16 04:22 PMAfter The Close: Juno Soars On CAR-T Drug Trial Restart; Pizza Hut Gets A Chatbot -
07/12/16 03:23 PM12/07/2016 GW Pharmaceuticals Announces Proposed Public Offering of ADSs - [at noodls] - c70d3184-71f6-46ab-898f-52f00753d023.pdf July 12, 2016 GW Pharmaceuticals Announces Proposed Public Offering of ADSs LONDON, July 12, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) ...
07/12/16 03:02 PM4:02 pm GW Pharma announces a $150 mln offering of American Depository Shares -
07/12/16 03:01 PMGW Pharmaceuticals Announces Proposed Public Offering of ADSs - [GlobeNewswire] - LONDON, July 12, 2016-- GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, ...
07/12/16 08:45 AMTrading Performance and Target Watch for GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
07/11/16 04:25 PMImpact Score and Stock Sentiment Outlook :GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
07/11/16 09:05 AMCompany Stock Focus for GW Pharmaceuticals Plc (NASDAQ:GWPH): Which Way Will Shares Head? - Press Telegraph
07/10/16 04:00 PMGW Pharmaceuticals Plc (NASDAQ:GWPH): Check on Company Stock Performance - Press Telegraph
07/10/16 08:45 AMPrice Target Review and Earnings Check on GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
07/10/16 08:45 AMNext Weeks Broker Price Targets For GW Pharmaceuticals Plc (GWPH) - Fiscal Standard
07/08/16 07:12 AMGW Pharmaceuticals (GWPH): Strong Industry, Solid Earnings Estimate Revisions - Yahoo Finance
07/07/16 04:27 PMGW Pharmaceuticals (GWPH): Strong Industry, Solid Earnings Estimate Revisions
07/06/16 03:20 PMHere's Why This Marijuana Stock Marched 10.6% Higher in June -
07/06/16 09:00 AMCan GW Pharmaceuticals Plc (NASDAQ:GWPH) Improve on the Earnings Front? - Engelwood Daily
07/06/16 09:00 AMWhich Way is Stock Sentiment Leaning on :GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
07/06/16 09:00 AMStock Rating Watch and Earnings Insight for GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
07/05/16 08:59 AMJanney Capital Initiates Coverage on GW Pharmaceuticals PLC- ADR to Sell - Trade Calls
07/05/16 08:03 AMNuVasive (NUVA) at 52-Week High on Strategic Initiatives -
07/01/16 04:23 PMGW Pharmaceuticals Plc (NASDAQ:GWPH) News Sentiment Recap - Press Telegraph
07/01/16 04:23 PMGW Pharmaceuticals Stock Price Update Today (GWPH) - July 01, 2016 - Money Morning
07/01/16 10:03 AMHow the DEA could introduce big pharma to marijuana -
06/30/16 04:39 PMCompany Target Price Watch: GW Pharmaceuticals Plc (NASDAQ:GWPH) - Telanagana Press
06/29/16 04:18 PMHC Stocks to Path: GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Relypsa Inc (NASDAQ:RLYP) - share market updates (press release)

Social

About GW Pharmaceuticals PLC-

GW Pharmaceuticals PLC- logoGW Pharmaceuticals plc is involved in the development of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. The Company develops a portfolio of cannabinoid medicines, including Epidiolex, which is an oral medicine for the treatment of refractory childhood epilepsies. The Company operates through three segments: Commercial, Sativex Research and Development (Sativex R&D), and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex R&D segment seeks to maximize the potential of Sativex through the development of indications. The Sativex R&D segment focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using the Company's cannabinoid technology platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GWPH
  • CUSIP:
Key Metrics:
  • Previous Close: $94.68
  • 50 Day Moving Average: $90.85
  • 200 Day Moving Average: $72.40
  • P/E Ratio: N/A
  • P/E Growth: 0.47
  • Market Cap: $2.07B
  • Beta: 3.02
  • Current Year EPS Consensus Estimate: $-4.19 EPS
  • Next Year EPS Consensus Estimate: $-4.91 EPS
Additional Links:
GW Pharmaceuticals PLC- (NASDAQ:GWPH) Chart for Monday, July, 25, 2016